Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I single and multiple ascending dose study of ADX71441 in healthy volunteers
NL-OMON38582Phase 1Active, not recruiting
- Sponsor
- Addex Therapeutics Ltd
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ADX71441 in Muscle spasm (3 arms), sponsored by Addex Therapeutics Ltd. Primary endpoints: Plasma concentration of ADX71441 and Pharmacodynamic evaluation. Started Apr 2013; status: active, not recruiting.
02
Drugs
ADX71441
03
Conditions
Muscle spasm
Beyond the preview
Go deeper on NL-OMON38582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38582.